Apr 25, 2023 / 03:00PM GMT
Unidentified Participant
We have Xenon Pharmaceuticals. And we have Ian Mortimer, President and CEO. Take it away, Ian.
Ian Mortimer - Xenon Pharmaceuticals Inc. - President & CEO
Thanks, Andrew. Good morning, everyone, and thanks for joining. It's been -- it's great to be back at the Bloom Burton conference. Lot of progress at Xenon over the last years, so nice opportunity to give you an update on.
I will be making some forward-looking statements, so I do refer you to our full risk factor disclosure filed with the SEC and also filed on SEDAR.
For those that are newer to the Xenon's story, we're a neurology company. We've built really strong capabilities of drugging ion channels in the CNS. We've been doing this for about 15 years or so.
Over the last number of years, we've built really strong capabilities in epilepsy drug development from preclinical modeling and pharmacology, all the way through clinical development. And our goal strategically is to forward integrate into a commercial organization, and we plan to launch our lead program
Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 25, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers